Published in
Esmo Open, Esmo Open, 6(7), p. 100634, 2022
DOI: 10.1016/j.esmoop.2022.100634
Links
Tools
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program
Journal article published in 2022 by
S. E. Rebuzzi,
A. Signori,
S. Buti,
G. L. Banna,
V. Murianni,
A. Damassi,
M. Maruzzo 
,
D. Giannarelli,
G. Tortora,
L. Galli,
M. Rizzo,
U. De Giorgi,
L. Antonuzzo ,
S. Bracarda,
G. Cartenì
and other authors.
,
D. Giannarelli,
G. Tortora,
L. Galli,
M. Rizzo,
U. De Giorgi,
L. Antonuzzo ,
S. Bracarda,
G. Cartenì
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 